Distler, U.* ; Yoo, H.B.* ; Kardell, O. ; Hein, D.* ; Sielaff, M.* ; Scherer, M.* ; Jozefowicz, A.M.* ; Leps, C.* ; Gomez-Zepeda, D.* ; von Toerne, C. ; Merl-Pham, J. ; Barth, T.K.* ; Tüshaus, J.* ; Giesbertz, P.* ; Müller, T.* ; Kliewer, G.* ; Aljakouch, K.* ; Helm, B.* ; Unger, H.* ; Frey, D.L.* ; Helm, D.* ; Schwarzmüller, L.E.* ; Popp, O.* ; Qin, D.* ; Wudy, S.I.* ; Sinn, L.R.* ; Mergner, J.* ; Ludwig, C.* ; Imhof, A.* ; Kuster, B.* ; Lichtenthaler, S.F.* ; Krijgsveld, J.* ; Klingmüller, U.* ; Mertins, P.* ; Coscia, F.* ; Ralser, M.* ; Mülleder, M.* ; Hauck, S.M. ; Tenzer, S.*
Multicenter evaluation of label-free quantification in human plasma on a high dynamic range benchmark set.
Nat. Commun. 16, 18:8774 (2025)
Human plasma is routinely collected during clinical care and constitutes a rich source of biomarkers for diagnostics and patient stratification. Liquid chromatography-mass spectrometry (LC-MS)-based proteomics is a key method for plasma biomarker discovery, but the high dynamic range of plasma proteins poses significant challenges for MS analysis and data processing. To benchmark the quantitative performance of neat plasma analysis, we introduce a multispecies sample set based on a human tryptic plasma digest containing varying low level spike-ins of yeast and E. coli tryptic proteome digests, termed PYE. By analysing the sample set on state-of-the-art LC-MS platforms across twelve different sites in data-dependent (DDA) and data-independent acquisition (DIA) modes, we provide a data resource comprising a total of 1116 individual LC-MS runs. Centralized data analysis shows that DIA methods outperform DDA-based approaches regarding identifications, data completeness, accuracy, and precision. DIA achieves excellent technical reproducibility, as demonstrated by coefficients of variation (CVs) between 3.3% and 9.8% at protein level. Comparative analysis of different setups clearly shows a high overlap in identified proteins and proves that accurate and precise quantitative measurements are feasible across multiple sites, even in a complex matrix such as plasma, using state-of-the-art instrumentation. The collected dataset, including the PYE sample set and strategy presented, serves as a valuable resource for optimizing the accuracy and reproducibility of LC-MS and bioinformatic workflows for clinical plasma proteome analysis.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
Publication type
Article: Journal article
Document type
Scientific Article
Thesis type
Editors
Keywords
Mass-spectrometry; Software Tools; Peptide Identification; Proteome; Depth
Keywords plus
Language
english
Publication Year
2025
Prepublished in Year
0
HGF-reported in Year
2025
ISSN (print) / ISBN
2041-1723
e-ISSN
2041-1723
ISBN
Book Volume Title
Conference Title
Conference Date
Conference Location
Proceedings Title
Quellenangaben
Volume: 16,
Issue: 1,
Pages: 18,
Article Number: 8774
Supplement: ,
Series
Publisher
Nature Publishing Group
Publishing Place
London
Day of Oral Examination
0000-00-00
Advisor
Referee
Examiner
Topic
University
University place
Faculty
Publication date
0000-00-00
Application date
0000-00-00
Patent owner
Further owners
Application country
Patent priority
Reviewing status
Peer reviewed
POF-Topic(s)
30203 - Molecular Targets and Therapies
Research field(s)
Enabling and Novel Technologies
PSP Element(s)
G-505700-001
Grants
German Ministry of Education and Research (BMBF), National Research Initiative Mass Spectrometry in Systems Medicine (MSCoreSys)
BMBF LiSyM-Cancer
German Center for Lung Research
HORIZON EUROPE of the European Research Council
German Research Foundation
DFG priority program SPP 2225
DFG Germany's Excellence Strategy
Research Center for Immunotherapy (FZI) of the Johannes Gutenberg-University Mainz
Copyright
Erfassungsdatum
2025-10-23